These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34849657)

  • 21. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
    Naveed Z; Li J; Wilton J; Spencer M; Naus M; Velásquez García HA; Kwong JC; Rose C; Otterstatter M; Janjua NZ;
    J Am Coll Cardiol; 2022 Nov; 80(20):1900-1908. PubMed ID: 36357091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?
    Mormile R
    Expert Rev Cardiovasc Ther; 2022 Feb; 20(2):87-90. PubMed ID: 35180029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
    Goddard K; Lewis N; Fireman B; Weintraub E; Shimabukuro T; Zerbo O; Boyce TG; Oster ME; Hanson KE; Donahue JG; Ross P; Naleway A; Nelson JC; Lewin B; Glanz JM; Williams JTB; Kharbanda EO; Katherine Yih W; Klein NP
    Vaccine; 2022 Aug; 40(35):5153-5159. PubMed ID: 35902278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
    Schauer J; Buddhe S; Colyer J; Sagiv E; Law Y; Mallenahalli Chikkabyrappa S; Portman MA
    J Pediatr; 2021 Nov; 238():317-320. PubMed ID: 34228985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Wong HL; Hu M; Zhou CK; Lloyd PC; Amend KL; Beachler DC; Secora A; McMahill-Walraven CN; Lu Y; Wu Y; Ogilvie RP; Reich C; Djibo DA; Wan Z; Seeger JD; Akhtar S; Jiao Y; Chillarige Y; Do R; Hornberger J; Obidi J; Forshee R; Shoaibi A; Anderson SA
    Lancet; 2022 Jun; 399(10342):2191-2199. PubMed ID: 35691322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study.
    Park H; Yun KW; Kim KR; Song SH; Ahn B; Kim DR; Kim GB; Huh J; Choi EH; Kim YJ
    J Korean Med Sci; 2021 Aug; 36(32):e232. PubMed ID: 34402230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
    Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
    J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.
    Mahasing C; Doungngern P; Jaipong R; Nonmuti P; Chimmanee J; Wongsawat J; Boonyasirinant T; Wanlapakorn C; Leelapatana P; Yingchoncharoen T; Ngarmukos T; Chokephaibulkit K; Srimahachota S
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons of the risk of myopericarditis between COVID-19 patients and individuals receiving COVID-19 vaccines: a population-based study.
    Chou OHI; Zhou J; Lee TTL; Kot T; Lee S; Wai AKC; Wong WT; Zhang Q; Cheng SH; Liu T; Vassiliou VS; Cheung BMY; Tse G
    Clin Res Cardiol; 2022 Oct; 111(10):1098-1103. PubMed ID: 35333945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022.
    Sim JY; Kim SY; Kim EK
    Osong Public Health Res Perspect; 2023 Apr; 14(2):76-88. PubMed ID: 37183328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination.
    Piché-Renaud PP; Morris SK; Top KA
    Br J Clin Pharmacol; 2023 Mar; 89(3):967-981. PubMed ID: 36480113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.
    Funk PR; Yogurtcu ON; Forshee RA; Anderson SA; Marks PW; Yang H
    Vaccine; 2022 Apr; 40(19):2781-2789. PubMed ID: 35370016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of BNT162b2 mRNA COVID-19 vaccine in children with chronic kidney disease: a national population study from South Korea.
    Choe YJ; Ahn YH; Gwak E; Jo E; Kim J; Choe SA
    Pediatr Nephrol; 2024 Feb; 39(2):625-629. PubMed ID: 37880380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
    Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
    Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocarditis and pericarditis are rare following live viral vaccinations in adults.
    Kuntz J; Crane B; Weinmann S; Naleway AL;
    Vaccine; 2018 Mar; 36(12):1524-1527. PubMed ID: 29456017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocarditis and Pericarditis Related to mRNA COVID-19 Vaccination: A Case Report.
    María PLE; Diego RS; Jorge NR
    Curr Drug Saf; 2024; 19(1):154-158. PubMed ID: 36999413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination.
    Kornowski R; Witberg G
    Open Heart; 2022 Mar; 9(1):. PubMed ID: 35264415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    Jeong HS; Chun BC
    PLoS One; 2024; 19(2):e0297902. PubMed ID: 38381729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination.
    Manno EC; Amodio D; Cotugno N; Rossetti C; Giancotta C; Santilli V; Zangari P; Rotulo GA; Villani A; Giglioni E; Turchetta A; Cafiero G; Franceschini A; Chinali M; Porzio O; Secinaro A; Palma P
    Pediatr Infect Dis J; 2023 Feb; 42(2):166-171. PubMed ID: 36638405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short term outcome of myocarditis and pericarditis following COVID-19 vaccines: a cardiac magnetic resonance imaging study.
    Galea N; Cundari G; Di Dedda E; Chimenti C; Aquaro GD; Barison A; Cau R; Di Cesare E; Di Renzi P; Esposito A; Faletti R; Gatti M; Liguori C; Lovato L; Mantini C; Monti CB; Palmisano A; Pradella S; Ricci F; Saba L; Secchi F; Catalano C; Francone M
    Int J Cardiovasc Imaging; 2023 May; 39(5):1031-1043. PubMed ID: 36913155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.